Chinese drug hydroxychloroquine, are not registered in the Russian Federation and permitted for the treatment of patients With coronavirus, security, and productivity is not different from the Russian counterparts, said the press service of the Ministry of health.
first it was announced that the Russian Federation has received from China almost 70 thousand packings of the hydroxychloroquine, and the government is instructed to apply the drug. From the outset, the hydroxychloroquine was intended to treat malaria, but showed himself as a remedy for COVID-19.
"From the standpoint of clinical pharmacology there are no restrictions to the use of the batch of hydroxychloroquine no, because its safety and productivity it has no differences from the first account holders in the Russian Federation of drugs With the same international non-proprietary names ", - told in the Ministry of health.
It stressed that for the production of Chinese hydroxychloroquine is used similar in terms of quality, active pharmaceutical ingredient, which is used in Russia.
According to Deputy General Director of Scientific center of expertise of means for medical use Ministry of health Vadim Merkulov, obtaining the GMP certificate confirms the congruence of the Chinese drug all international requirements, and serves as an additional guarantee certificate of quality for the series, presented by the manufacturer.
Pandemic coronavirus infection COVID-19 affected the in practice the whole world. According to the final data of the who, has infected about 2-x million people, about 140 thousand died. In Russia, it has identified nearly 37 thousand infected with coronavirus (last night - 4785), 313 people died, more than three thousand has already been discharged from hospitals.
in China, where the disease spread worldwide, a few weeks ago announced the end of the epidemic.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.
<span style="color:darkgray
sections: Politics |